Phase I study of pevonedistat combined with capecitabine and oxaliplatin in patients with platinum-refractory advanced gastric cancer

H Hirokazu Shoji (Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo) D Daisuke Takahari A Akira Ooki H Hidekazu Hirano N Natsuko Okita K Kengo Nagashima J Jun Adachi K Kensei Yamaguchi K Ken Kato (Institute for Protein Research, The University of Osaka, 3-2 Yamadaoka, Suita-shi, Osaka 565-0871, Japan) N Narikazu Boku

Article Details

Volume / Issue Vol. 16, Issue 1
Published December 05, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (10)

H

Hirokazu Shoji

Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo

D

Daisuke Takahari

A

Akira Ooki

H

Hidekazu Hirano

N

Natsuko Okita

K

Kengo Nagashima

J

Jun Adachi

K

Kensei Yamaguchi

K

Ken Kato

Institute for Protein Research, The University of Osaka, 3-2 Yamadaoka, Suita-shi, Osaka 565-0871, Japan

N

Narikazu Boku